[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"lumbago\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:lumbago":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,69],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100555413","phase-3-anesthetic-block-of-the-erector-muscles-of-the-lumbar-spine-to-relieve-acute-lumbar-pain-pilot-study-100555413",false,"NCT06511765","Anesthetic Block of the Erector Muscles of the Lumbar Spine to Relieve Acute Lumbar Pain: Pilot Study","Inclusion Criteria:\n\n1. Patient with lumbago lasting less than 7 days despite analgesic \u002F NSAID treatment.\n2. Patient with NS pain \\> 6\n3. Patient with Oswestry score \\> or equal to 30\n4. Patient informed of the trial and having signed the informed consent form prior to any trial-specific procedure,\n5. Patient willing and able to undergo all planned examinations and procedures in compliance with the clinical trial protocol,\n6. Patient affiliated to a social security or any health insurance.\n\nExclusion Criteria:\n\n1. Presence of \"red flag\" (non-disc lumbago):\n\n   * Motor deficit or signs of horsetail irritation\n   * Inflammatory pain waking up in the 2nd half of the night\n   * Tumoral context\n   * Infectious context or fever\n   * Altered general condition\n   * Traumatic context\n   * Osteoporotic context\n2. Risk of infection\n3. Patient with poor local skin condition\n4. Patient on AVK or anti-Xa anticoagulation, or bleeding disorder (antiaggregants authorized)\n5. Patients with hypersensitivity to Ropivacaine or any of its excipients: Sodium chloride, hydrochloric acid sodium hydroxide\n6. Patient with sciatica\n7. Patient with chronic respiratory insufficiency\n8. Patient with cardiac rhythm disorders\n9. Pregnant or breastfeeding woman or woman refusing effective contraception\n10. Patient deprived of liberty or under legal protection (guardianship or curator)\n11. Patient participating in another clinical research protocol involving a drug or medical device\n12. Patient unable to follow the protocol, as judged by the investigator\n13. Patient refusing to participate in the study","ALL","18 Years",{"count":18,"type":19},40,"ESTIMATED","INTERVENTIONAL",[22],"PHASE3","This study concerns the treatment of recent lumbago and aims to evaluate the efficacy of an anesthetic block of the erector spinae muscles combining ropivacaine and dexamethasone. This treatment is routinely used in several institutions in France, but has never been the subject of a randomized placebo-controlled study to assess its efficacy at D4 of treatment.\n\nThe BLOCLOMB comparative, randomized, double-blind study aims to validate the efficacy, over the first 4 days, of anesthetic blocks of the erector spinae muscles, during recent lumbago, on the pain of muscular contractures.",[25],"Lumbago",[27,28],"anesthetic blocks","pain","RECRUITING","2026-06-08",{"date":32,"type":33},"2026-06-10","ACTUAL",{"date":35,"type":33},"2026-03-24",{"date":37,"type":19},"2026-10-31",{"name":39,"class":40},"Elsan","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":49,"targetDuration":51,"studyType":52,"phases":4,"briefSummary":53,"conditions":54,"keywords":55,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":41},"100628881","treatment-of-mechanical-low-back-pain-with-high-intensity-focused-ultrasound-hifu-100628881","NCT07467408","Treatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU)","Prospective Observational Study of the Treatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU) of the Lumbar Medial Branch.","Inclusion Criteria:\n\n* Over 18 years of age.\n* Signed informed consent for data collection.\n* Mechanical low back pain with a positive diagnostic block (\\>30% pain reduction) of the lumbar medial ramus with local anaesthetic.\n\nExclusion Criteria:\n\n* Presence of pain with mixed characteristics or suspected multiple aetiology of the low back pain (e.g. sacroiliac joint involvement).\n* Active systemic infection.\n* Pregnancy.\n* History of spinal surgery at the level of treatment.\n* Presence of tumours, metastatic disease or osteoporosis in the treatment area.\n* Pacemaker or implantable generator carriers.\n* Coagulation disorders or thrombocytopenia.\n* Vertebral fracture or compression at the treatment level.\n* Medical condition contraindicating sedation or the treatment position.",{"count":50,"type":19},60,"6 Months","OBSERVATIONAL","High-intensity focused ultrasound (HIFU) is an emerging technology that allows for the targeted thermal ablation of deep tissues in a non-invasive manner, by concentrating acoustic energy on the target nerve, whilst preserving adjacent structures. Recently, open clinical studies have confirmed the feasibility, safety and efficacy of HIFU in patients with lumbar facet syndrome, with clinical response rates similar to those of RFA and no significant complications.\n\nThis observational, prospective, non-interventional study aims to evaluate the clinical efficacy of lumbar medial branch ablation using this technique at 1, 3 and 6 months, as well as to assess patient satisfaction with the procedure. Only clinical data from patients undergoing the procedure in routine clinical practice will be collected.",[25],[56,57,58],"Chronic Pain","Lumbalgia","HIFU","NOT_YET_RECRUITING","2026-03-12",{"date":62,"type":33},"2026-03-16",{"date":64,"type":19},"2026-04-01",{"date":66,"type":19},"2026-12-31",{"name":68,"class":40},"Consorci Sanitari de Terrassa",{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":77,"targetDuration":4,"studyType":20,"phases":79,"briefSummary":81,"conditions":82,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":41},"100510230","cardiovascular-risk-in-digital-osteoarthritis-100510230","NCT05923736","Cardiovascular Risk in Digital Osteoarthritis","Assessment of Cardiovascular Risk in Digital Osteoarthritis: A Case-control Study.","RICARDI","Inclusion Criteria:\n\nFor all subjects:\n\n* Adult male or female subject\n* Able to give informed consent to participate in research\n* Affiliated with a Social Security plan\n\nFor the digital osteoarthritis group:\n\n* Consultant in Rheumatology at Clermont-Ferrand University Hospital\n* Affected by digital osteoarthritis meeting ACR diagnostic criteria with radiographic signs of osteoarthritis validated by a radiologist.\n\nFor the control group :\n\n* Rheumatology consultant at the Clermont-Ferrand University Hospital or hospitalized in this department for a non-arthritic, non-rheumatic pathology.\n* Patients with spinal disc pathology (lumbago, radiculalgia due to disco-radicular conflict) or non-severe osteoporosis, i.e. with a densitometric T score between -2.5 and -3 DS.\n\nExclusion Criteria:\n\nFor all topics :\n\n* Refusal to participate\n* Pregnant women, nursing mothers\n* Subjects under guardianship or curatorship, deprived of liberty, or under court protection\n\nFor the digital osteoarthritis group:\n\n\\- Existence of diagnostic arguments for another inflammatory rheumatism (rheumatoid arthritis, spondylarthritis, psoriatic arthritis, lupus, gout, chondrocalcinosis...) or another arthrosic localization (gonarthrosis, coxarthrosis, discarthrosis) symptomatic at the time of inclusion or affecting daily activities.\n\nFor the control group :\n\n* Existence of chronic inflammatory rheumatism (rheumatoid arthritis, spondylitis, psoriatic arthritis, lupus, gout, chondrocalcinosis...)\n* Existence of digital osteoarthritis\n* Existence of another painful arthritic site (knee, hip, rachi) Existence of finger pain, whatever the etiology.",{"count":78,"type":19},100,[80],"NA","The goal of this cross-sectional case control study is to investigate the cardiovascular risk in digital osteoarthritis. This study aims to compare the cardiovascular risk between group of patients with digital osteoarthritis and control group of patients with non-osteoarthritis disease paired by measurement of carotid intima-media thickness. All participants will undergo an ultrasound scan to measure carotid intima media thickness, a clinical assessment with the rheumatologist and a cardiovascular risk assessment.",[83,25,84,85],"Osteoarthritis Hand","Osteoporosis","Radiculopathy Lumbar","2024-04-02",{"date":88,"type":33},"2024-04-03",{"date":90,"type":33},"2023-10-04",{"date":92,"type":19},"2026-10-04",{"name":94,"class":40},"University Hospital, Clermont-Ferrand"]